Most children who catch COVID have mild illness and recover quickly. We identified key proteins in kids who’d had severe COVID with painful inflammation or respiratory failure.
Articles on MIS-C
Displaying all articles
Scientists are still working to understand this rare COVID syndrome in children.
Regulators are currently reviewing the safety and efficacy data of the Pfizer vaccine for five to 11 year olds before deciding whether to approve its use in this age group.
Even kids who were asymptomatic when they had COVID-19 have developed multisystem inflammatory syndrome, a new review of hundreds of cases shows.
A rare new disease syndrome appears to be caused by an overactive immune response in children, often hitting weeks after exposure to the SARS-CoV-2 virus.
Top contributors
-
Vice Chancellors Senior Research Fellow in Immunology, RMIT University
-
Associate Professor, Pediatric Infectious Diseases, Vanderbilt University
-
Strategic Advisor, Neuroscience Trials Australia, Florey Institute of Neuroscience and Mental Health, The University of Melbourne
-
Senior Lecturer; MD, Victoria University
-
PhD Student, Murdoch Children's Research Institute
-
Professor of Immunology, The University of Queensland
-
Distinguished Professor, Professor of Immunology, RMIT University
-
Instructor in Biology, University of Winnipeg